Proline oxidase is a p53-induced redox gene that can generate reactive oxygen species (ROS) and mediate apoptosis in tumor cells. We report that proline oxidase is a downstream effector in p53-mediated activation of the calcium/calmodulin-dependent phosphatase calcineurin in lung, renal, colon, and ovarian carcinoma cells. The activation of calcineurin by p53 and proline oxidase was detected by activation of the nuclear factor of activated T cells (NFAT), an established indicator of activated calcineurin. Both proline oxidase-and p53-induced activation of NFAT were sensitive to the calcineurin inhibitors cyclosporin A and FK-506, to scavengers of ROS, and to inhibitors of calcium mobilization. A proline oxidase antisense vector suppressed the ability of p53 to up-regulate proline oxidase, activate calcineurin, and induce apoptosis. Moreover, two renal carcinoma-derived mutant p53 proteins were deficient in inducing proline oxidase expression and in activating calcineurin. Inhibitors of calcineurin and calcium mobilization abolished proline oxidase-mediated apoptosis and reduced p53-induced apoptosis. Treatment of colon and ovarian carcinoma cells with the anticancer genotoxic agent etoposide upregulated both p53 and proline oxidase, activated calcineurin, and induced apoptosis. The etoposide-mediated activation of calcineurin and induction of apoptosis was markedly suppressed by FK-506 calcineurin inhibitor. We propose that proline oxidase mediates apoptosis through the generation of proline-dependent ROS, which then mobilize calcium and activate calcineurin. The activation of calcineurin-regulated transcription factor pathways by proline oxidase might affect gene expression events important to p53 regulation of cell growth and apoptosis.
Proline oxidase is a p53-induced redox gene that can generate reactive oxygen species (ROS) and mediate apoptosis in tumor cells. We report that proline oxidase is a downstream effector in p53-mediated activation of the calcium/calmodulin-dependent phosphatase calcineurin in lung, renal, colon, and ovarian carcinoma cells. The activation of calcineurin by p53 and proline oxidase was detected by activation of the nuclear factor of activated T cells (NFAT), an established indicator of activated calcineurin. Both proline oxidase-and p53-induced activation of NFAT were sensitive to the calcineurin inhibitors cyclosporin A and FK-506, to scavengers of ROS, and to inhibitors of calcium mobilization. A proline oxidase antisense vector suppressed the ability of p53 to up-regulate proline oxidase, activate calcineurin, and induce apoptosis. Moreover, two renal carcinoma-derived mutant p53 proteins were deficient in inducing proline oxidase expression and in activating calcineurin. Inhibitors of calcineurin and calcium mobilization abolished proline oxidase-mediated apoptosis and reduced p53-induced apoptosis. Treatment of colon and ovarian carcinoma cells with the anticancer genotoxic agent etoposide upregulated both p53 and proline oxidase, activated calcineurin, and induced apoptosis. The etoposide-mediated activation of calcineurin and induction of apoptosis was markedly suppressed by FK-506 calcineurin inhibitor. We propose that proline oxidase mediates apoptosis through the generation of proline-dependent ROS, which then mobilize calcium and activate calcineurin. The activation of calcineurin-regulated transcription factor pathways by proline oxidase might affect gene expression events important to p53 regulation of cell growth and apoptosis.
The p53 protein maintains the genomic stability of cells and reduces the probability that an individual will develop cancer. Loss of p53 function is frequently associated with a broad spectrum of human cancers (1) , and transgenic mice lacking p53 are inherently predisposed to tumors at a young age (2) . The p53 protein functions as a sequence-specific DNA-binding factor that can activate genes whose promoters contain a p53 response element (reviewed in Refs. [3] [4] [5] [6] [7] [8] [9] . A number of genes involved in control of the cell cycle and apoptosis are regulated by p53. By using the SAGE (serial analysis of gene expression) technique to evaluate the patterns of gene expression following p53 expression, a series of p53-induced genes (PIGs) 1 have been identified that are predicted to encode proteins that could generate or respond to oxidative stress (10) . Some PIGs encode factors that induce the intracellular accumulation of reactive oxygen species (ROS). The accumulation of ROS, in turn, may sensitize cells to stress and, thus, induce apoptosis. The PIG3 product is closely related to oxidoreductases and has been implicated in regulating the stability of p53, potentially as a result of controlling the intracellular redox state (11) . The PIG6 (proline oxidase-1) gene can generate ROS and induce apoptosis in renal, colon, and lung carcinoma cells (12) (13) (14) (15) , and its expression is frequently altered in primary renal tumors (14) . Lack of expression of PIG6 in two primary renal carcinomas was associated with mutated p53s, which were considerably less effective in up-regulating the PIG6 gene relative to the normal p53 protein (14) .
Additional evidence implicating a direct role for redox enzymes in p53-mediated apoptosis is derived from a study of a p53 mutant (p53⌬62-91) deleted in the proline-rich domain (amino acids 62-91) that can mediate growth arrest but not apoptosis (16, 17) . The inability of p53⌬62-91 to induce apoptosis correlated with a selective defect in transcriptional activation. Although p53⌬62-91 activates the p21 promoter and many other p53-responsive promoters, its ability to activate a transiently transfected PIG3 promoter (18) and the expression of endogenous PIG3, PIG6, and PIG11 turned out to be severely reduced (19) . Some tumor-derived mutations within the DNA binding domain of p53 result in a phenotype resembling p53⌬62-91 (20) . This correlation further supports the model (10) that PIGs are mediators of p53-induced apoptosis.
ROS play roles as intracellular second messengers in signaling cascades and induce gene expression by stimulating signal transduction components such as Ca 2ϩ signaling/mobilization and protein phosphorylation (21) (22) (23) (24) (25) . Because ROS can mobilize Ca 2ϩ and proline oxidase can generate proline-dependent ROS, we decided to investigate whether proline oxidase could activate the nuclear factor of activated T cells (NFAT) transcription factor, which is regulated by calcium/calmodulin-dependent calcineurin (26, 27) . Calcineurin, also known as protein phosphatase 2B, is a serine/threonine-specific phosphatase activated by Ca 2ϩ /calmodulin (28) . When activated by Ca 2ϩ , calcineurin dephosphorylates the NFAT transcription factor complex (28, 29) , which undergoes cytoplasmic-to-nuclear translocation (30) where it regulates genes whose promoters contain NFAT binding sites, including genes encoding interleukin-2, interleukin-3, interleukin-4, FasL, and inositol 1,4,5,-triphosphate receptor type 1 (31) . NFAT was originally described as a transcription factor expressed in activated but not resting T cells (32, 33) . However, NFAT is now known to be expressed in brain, heart, skeletal muscle, testis, placenta, pancreas, small intestine, prostate, colon, ovary, and kidney (31) . NFATs are ubiquitously expressed as a family of five transcription factors (NFATC1-C5), which control gene expression influencing the development and adaptation of numerous nonimmune mammalian cell types (reviewed in Ref. 27 ). NFATC2, NFATC3, and NFATC4 have been implicated in playing a role in apoptosis (34, 35) , cell cycle control (36) , and cell survival (37) .
We show here that calcineurin is activated in nonsmall cell lung, ovarian, and colon carcinoma cells by p53 through the induction of the expression of proline oxidase (POX). Two renal carcinoma-derived p53 mutants were defective in up-regulating POX and activating NFAT. Additional evidence for a direct role for POX in the p53-mediated activation of calcineurin was provided by POX antisense experiments. Calcium chelators, ROS scavengers, and inhibitors of calcineurin suppressed both p53-and POX-induced apoptosis and activation of NFAT. Treatment of cells with the DNA-damaging chemotherapeutic agent etoposide induced p53 and POX and activated calcineurin. Inhibition of calcineurin and repression of POX expression markedly suppressed etoposide-induced apoptosis. The results implicate POX-mediated activation of calcineurin as a novel downstream pathway in p53-induced apoptosis.
MATERIALS AND METHODS
Cell Lines-H1299 nonsmall cell lung, TOV-21G ovarian, and DLD1 colon adenocarcinoma cell lines were obtained from the American Tissue Type Collection. H1299 cells were propagated in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum. TOV-21G cells were grown in a 1:1 mixture of MCDB 105 medium (Sigma) and medium 199 (Invitrogen) supplemented with 15% fetal bovine serum. DLD1 cells were maintained in RPMI medium containing 10% fetal bovine serum.
Calcium and ROS Modifiers-All chemicals were obtained from Sigma-Aldrich. The calcineurin inhibitors cyclosporin A and FK-506 were dissolved in Me 2 SO and ethanol, respectively. The hydroxyl radical scavengers benzoate and dimethylthiourea, the H 2 O 2 scavenger Nacetyl-L-cysteine, and the calmodulin agonist trifluoperazine were dissolved in water. The cell-permeable calcium chelator 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid (BAPTA), the calcium channel blocker nifedipine, and etoposide were solubilized in Me 2 SO.
Antibodies, Expression Plasmids, and Recombinant AdenovirusesThe p53 monoclonal antibody Bp53-12 was purchased from Santa Cruz Biotechnology, and the actin monoclonal antibody (N350) was from Amersham Biosciences. A POX antibody (T338) was generated in rabbits against a synthetic peptide composed of amino acids 254 -269 of the POX protein (TGQLEPLLSRFTEEEE) (14) . Kidney p53 cDNAs isolated by reverse transcription PCR from primary kidney tissues were cloned into the pcDNA3.1 ECHO expression system (Invitrogen). The complete POX cDNA was cloned into the pAdtrack vector, which coexpresses green fluorescent protein (GFP) as a normalization control for transfection efficiency (14) . The pAdtrack-POX vector was used to generate a recombinant adenovirus using a simplified procedure as described previously (38) . The POX and a wild type p53 recombinant adenovirus were amplified in 293 cells and isolated by freeze-thawing 293 cells in phosphate-buffered saline. A NFAT luciferase reporter plasmid (3xNFAT-Luc) and an expression plasmid encoding GFP-VIVIT, a specific inhibitor of NFAT, have been described previously (39) .
Transient Transfection and Western Blotting-Adenovirus infections and Lipofectamine-mediated transfections were conducted as described previously (14) . Briefly, for gene transfections a T75 flask of confluent cells was incubated for 2 h at 37°C in 7 ml of Opti-MEM medium (Invitrogen) containing 10 -15 g of DNA and 18 l of Lipofectamine 2000 (Invitrogen). The transfection medium was then replaced with Dulbecco's modified Eagle's medium, and the cells were incubated for 24 -36 h to allow expression of the transfected gene. To normalize for transfection efficiency, pAdtrack, which expresses GFP, was included in the transfection assay where appropriate. For adenovirus infections, cells were incubated in complete cell culture medium containing 50 plaque-forming units of adenovirus per cell for 24 -42 h. Western blotting was performed using the SuperSignal immunodetection system (Pierce Chemical) as described previously (14) .
NFAT-Luciferase Reporter Assay-Luciferase reporter gene assays were performed in 12-well culture dishes. Cells (1.6 ϫ 10 4 /well) were transfected with 1 g of NFAT luciferase reporter gene and 1 g of each expression vector or infected with 50 plaque-forming units/cell with recombinant adenovirus, as described above. After a 24-h incubation in Dulbecco's modified Eagle's medium and 10% fetal bovine serum, cells were washed once with 1ϫ phosphate-buffered saline, and luciferase activity was assayed as per the manufacturer's instructions (Promega). To normalize for transfection efficiency, a ␤-galactosidase reporter vector was used according to the manufacturer's instructions (Promega). All experiments were repeated at least three times with different cell preparations. To determine the effect of different calcium and ROS modifiers on NFAT activation by p53 or POX, cells were cotransfected with NFAT and ␤-galactosidase reporter vectors and with GFP, p53, or POX recombinant adenoviruses for 18 h. The calcineurin inhibitors, ROS squelchers, and calcium modifiers were added to the cell medium at the time of p53 or POX adenovirus infection. Cells were then incubated in the presence of adenovirus and drugs for the designated amount of time. Dose-response curves were performed for each of the drugs to determine the amount required to induce 50 -70% cell death after 36 h.
ELISA Apoptosis Assay-The Cell Death Detection ELISA system (Roche Applied Science) is a photometric enzyme immunoassay for the quantitative in vitro determination of cytoplasmic histone-associated DNA fragments (mononucleosomes and oligonucleosomes) after induced apoptotic cell death. Briefly, transfection of H1299 cells with GFP-VIVIT was performed 5 h before infection with GFP, p53, or POX recombinant adenoviruses. The calcineurin inhibitors, the hydroxyl radical scavengers, the H 2 O 2 scavenger, the cell-permeable calcium chelator, the calcium channel blocker, and the calmodulin agonist mentioned above were added to the cell medium simultaneously with p53 or POX adenovirus infection for 36 h. Cell lysates were prepared according the manufacturer's specifications and placed into a streptavidin-coated microplate along with a mixture of biotinylated anti-histone (binds to histones H1, H2A, H2B, H3, and H4 from various species, e.g. man, mouse, rat. hamster, cow, opossum, and Xenopus) and anti-DNA covalently linked to peroxidase (reacts with single-and double-stranded DNA). The biotinylated anti-histone antibody binds to the histonecomponent of the nucleosomes, and the biotinylated antibody-histone immunocomplex is captured by binding to the streptavidin-coated microplate. Finally, the peroxidase-conjugated anti-DNA antibody reacts with the DNA-component of the nucleosomes. Unbound components (antibodies) were removed by a washing step. Quantitative determination of the amount of nucleosomes was determined photometrically using the peroxidase substrate 2,2Ј-azinobis-(3-ethyl-benzothiazoline-6-sulfonic acid), at 405 nm.
RESULTS

p53 and POX Activate NFAT through ROS-and Calciumsensitive Pathways-ROS can mobilize Ca
2ϩ , which activates the Ca 2ϩ /calmodulin-dependent phosphatase calcineurin. The dephosphorylation of NFAT by activated calcineurin results in its translocation into the nucleus, where it activates genes containing NFAT response elements. Because p53 can generate ROS through the induction of POX, we investigated whether p53 and POX could increase NFAT activity, a biochemical indicator of activated calcineurin. We examined the activity of NFAT by using the 3xNFAT-luciferase reporter gene under control of three NFAT response elements in H1299 p53-null cells up-regulated for normal p53 (Np53). As shown in Fig. 1A , up-regulation of Np53 induced significant activation of the NFAT reporter gene (ϳ7-8-fold) when compared with the activity measured in cells transfected with GFP, indicating that the NFAT transcription factor had been activated in response to up-regulation of p53. We next compared the ability of two renal carcinoma-derived mutant p53s, T4p53 and T7p53, for their ability to activate NFAT. The T4p53 contains a double transition mutation at amino acid residues 125 (A125T) and 193 (R193H), and T7p53 harbors a single transition mutation at amino acid 149 (S149F). Even though both the T4p53 protein and the T7p53 protein were expressed at much higher levels in H1299 cells than Np53 (Fig. 1B) , they were considerably less capable of activating NFAT than Np53 (Fig. 1A) . Both mutant p53s were also less capable of inducing the POX protein than the Np53, with the T4p53 being the most defective in this respect (Fig. 1B) . The level of NFAT activation correlated closely with the differential abilities of mutant and normal p53s to up-regulate POX (Fig. 1B) . Because the activation of NFAT is a biochemical indicator for activated calcineurin, the close correlation of the deficient abilities of two mutant p53s to induce POX expression with their lower capabilities to activate NFAT suggested a direct role for POX in p53-mediated activation of calcineurin.
Over one-half of all human cancers contain missense p53 mutations, and ϳ80% of these mutations localize to the DNA binding domain. Many of these mutants lose the ability to bind DNA and activate transcription, rendering them incompetent to induce cell cycle arrest or apoptosis. Overexpression experiments in cell cultures have suggested that missense p53 mutations represent dominant negative phenotypes. p53 mutations in the core domain are classified into two types (40) . Mutations such as those at the mutational hotspots Arg-248 and Arg-273 occur in the DNA contact areas on either the L3 loop or the nearby loop-sheet-helix motif of p53 and are termed class I mutations. Class II mutations, such as those at Arg-175, occur in areas important for the conformational stability of p53 protein, such as the L2 loop in the zinc region, leading to conformational changes that expose the mutant-specific epitope of the PAb240 antibody and result in the loss the wild-type-specific epitope detected by PAb1620. In a number of experimental systems the conformational mutants were shown to be more oncogenic than the DNA-binding mutants. We predicted that the T4 and T7 represent conformational mutants of p53, because the mutations in the T4 mutant (A125T and A193H) and T7 mutant (S149F) fall in regions that are not directly involved in DNA binding. However, the A125T mutation in the T4 mutant does fall in somewhat close proximity to Lys-120, which is located in the loop 1 region forming the major groove DNA contact. We thus investigated the ability of the T4 and T7 mutants to act as dominant negatives of normal p53 activation of the NFAT reporter gene. As shown in Fig. 1C , coexpression of either the T4 or the T7 mutant p53 with normal p53 (Np53 T4 and Np53 T7) resulted in significant repression of the ability of Np53 to activate NFAT. The T4 double mutant proved most effective in dominant negative activity against Np53 and was also able to repress the residual activation of NFAT by the weaker T7 mutant (T4 T7 in Fig. 1C) . The dominant negative activities of these mutants on normal p53 activation of NFAT correlated well with their reduced abilities to induce POX expression. We are currently exploring further the conformational phenotypes of the T4 and T7 mutants and their potential dominant negative effects on the ability of normal p53 to induce apoptosis.
To further explore the role of POX in p53-mediated activation of calcineurin, we investigated whether POX could directly induce the activation of NFAT in H1299 cells. As shown in Fig.  2A , infection of H1299 cells with a POX adenovirus led to high activity of the NFAT luciferase reporter gene relative to control cells infected with a GFP adenovirus. To determine the specificity of our assay with respect to activation of NFAT, we added a specific peptide inhibitor of NFAT in the POX and p53 NFAT reporter assays. The peptide, VIVIT, inhibits NFAT activation and NFAT-dependent expression of endogenous cytokine genes in T cells without affecting the expression of other cytokines that require calcineurin but not NFAT (39) . The repression of POX-and p53-induced activation of the NFAT reporter gene by the specific NFAT peptide inhibitor VIVIT (Fig. 2, A and B) indicated that activated NFAT and not some other factor that spuriously activated the NFAT reporter gene in H1299 cells was detected by our assays. Both p53-induced activation and (T7p53 and T4p53) . C, dominant negative effects of mutant p53s on normal p53 activation of calcineurin/NFAT. Each mutant p53 (T4 and T7) was cotransfected with Np53 and the NFAT reporter gene into H1299 cells for 24 h. NFAT-luciferase reporter gene assays were then performed as described under "Materials and Methods." Controls included nontransfected cells (NT) and GFP-transfected cells. In this experiment, we used 2 g of each plasmid, which resulted in considerably more optimized detection of NFAT reporter gene activation than the experiment shown in Panel A, where only 1 g of DNA was applied. Both T4 and T7 exhibited dominant negative effects on the ability of normal p53 to activate NFAT, with the T4p53 being the most inhibitory.
POX-induced activation of NFAT were sensitive to the well characterized calcineurin inhibitors cyclosporin A (CsA) and FK-506, (Fig. 2, A and B) , indicating a role for calcineurin in POX-and p53-induced activation of NFAT.
Up-regulation of POX can generate increases in proline-dependent ROS production (13) (14) (15) . ROS act as intracellular second messengers in signaling cascades and influence gene expression by stimulating signal transduction components such as Ca 2ϩ signaling. To determine whether the p53-and POXmediated activation of NFAT was sensitive to ROS and calcium, we treated cells up-regulated for p53 and POX with various calcium and ROS modifiers. H1299 cells were first transfected with the NFAT reporter gene followed by infection with GFP, POX, or p53 adenoviruses for 24 h in the presence of a particular ROS or calcium modifier. The hydroxyl radical scavengers benzoate (Fig. 2, A and B, BZO) (41) and dimethylthiourea (Fig. 2, A and B, DMTU) (42) and the H 2 O 2 scavenger N-acetyl-1-cysteine (Fig. 2, A and B, AcCys) (43) inhibited p53-induced (Fig. 2B ) and POX-induced ( Fig. 2A) activation of NFAT to varying degrees. The N-acetyl-1-cysteine scavenger proved to be the most effective inhibitor of both POXand p53-induced NFAT activation. The calcium channel blocker nifedipine (Fig. 2, A and B, NFDP) (44), the cell-permeate calcium chelator BAPTA (45) , and the calmodulin antagonist trifluoperazine (Fig. 2, A and B, TPRZ) (46) were also effective inhibitors. Western blotting, as well as a visual analysis of GFP fluorescence, showed that each of these agents had little effect on adenovirus infection and transgene expression, because the induction of p53 expression was equivalent in both control and drug-treated cells (Fig. 2C) . These data suggested a dependence of the p53-and POX-induced activation of NFAT on ROS-and calcium-signaling pathways. The results also suggested that POX is a primary mediator of the p53-induced activation of NFAT, because the degrees of inhibition by the drugs on POX-induced activation of NFAT were similar to those observed for p53.
A POX antisense expression experiment confirmed a role for POX in p53-mediated activation of NFAT. As shown in Fig. 3 , coexpression of a POX antisense expression vector in p53-induced cells suppressed p53-induced expression of POX and blocked p53-induced activation of NFAT. This same POX antisense vector also suppressed the ability of p53 to induce apoptosis in 786-0 renal carcinoma cells (14) . As presented below, the POX antisense vector could also suppress p53-dependent activation of NFAT in the p53-dependent etoposide-induced DNA damage response in DLD1 colon and TOV-21G ovarian carcinoma cells as well.
Calcineurin Plays a Role in p53-and Proline Oxidase-induced Apoptosis-A role for calcineurin/NFAT in POX-induced apoptosis was investigated in H1299 nonsmall cell lung carcinoma cells. Cells were infected with POX adenovirus and then treated with the calcineurin inhibitors CsA and FK-506. The incidence of apoptosis was determined 30 h after infection by the Cell Death Detection ELISA, which is based on a quantitative sandwich-enzyme-immunoassay principle using mouse monoclonal antibodies directed against DNA and histones, respectively. This allows the specific detection and quantitation of mononucleosomes and oligonucleosomes that are released into the cytoplasm of cells that die from apoptosis but not necrosis. As shown in Fig. 4 , more oligonucleosomes were present in the cytoplasm of cells up-regulated for POX and p53 than in the cytoplasm of cells up-regulated for GFP, indicating the induction of significant apoptosis in POX and p53-induced cells. Incubation of POX-induced cells in the presence of CsA (Fig. 4, POX CsA) resulted in the formation of substantially fewer cytoplasmic oligonucleosomes, suggesting a role for calcineurin/NFAT in POXmediated apoptosis. However, CsA can prevent apoptosis by acting as an inhibitor of the mitochondrial permeability transition pore and preventing cytochrome c release (47) . We thus could not M calcium channel blocker nifedipine (NFDP), 1.25 mM H 2 O 2 scavenger N-acetyl-1-cysteine (AcCys), 1.8 mM hydroxyl radical scavenger dimethylthiourea (DMTU), or 0.1 mM hydroxyl radical scavenger benzoate (BZO) was included in NFAT reporter gene assays. H1299 cells were first transfected with the NFAT reporter gene and then infected for 24 h with GFP, POX, or the p53 recombinant adenovirus in the absence or presence of drugs. Dose-response curves for each drug were performed, and the concentrations producing ϳ30 -70% inhibition of NFAT luciferase reporter gene activity after 24 h are shown. For the NFAT peptide inhibitor assays, cells were first co-transfected with the NFAT reporter gene and GFP-VIVIT plasmid followed by adenovirus infection for 24 h. Luciferase assays were performed as described under "Materials and Methods." Prior dose-response curves determined the optimal amount of drugs in each assay. C, Western blotting of p53 and actin in p53-infected H1299 cells in the presence of drugs showed that the drugs had no effect on virus infection or protein expression. differentiate between a direct effect of CsA on mitochondrial membrane permeability and its inhibition of calcineurin in the inhibition of POX-induced apoptosis. To more definitively determine the role of calcineurin in POX-and p53-induced apoptosis, we applied FK-506 to the cells prior to apoptosis assays. FK-506 is a calcineurin inhibitor that does not affect the mitochondrial permeability transition pore (48) and was quite effective in blocking POX-mediated apoptosis (Fig. 4, POX FK506) , strongly suggesting that POX-mediated apoptosis is dependent on calcineurin. The effect of these agents on p53-induced apoptosis was less impressive, with an ϳ30% reduction in the presence of CsA and FK-506 (Fig. 4, p53 CsA and p53 FK506) . We conclude that blocking primarily the calcineurin pathway has less of an effect on p53-induced apoptosis than on POX-induced apoptosis. We propose that POX primarily mediates apoptosis through the calcineurin pathway, whereas calcineurin signaling is only one of several pathways that mediate p53-induced apoptosis. This would explain why calcineurin appears to play a lesser overall role in the p53 apoptotic process than in POX-induced apoptosis.
A role for the NFAT/calcineurin pathway was investigated in p53-dependent apoptosis in DLD1 colon and TOV-21G ovarian carcinoma cells. Etoposide is a genotoxic agent that is known to up-regulate p53 and activate its DNA binding activity. Concentrations of etoposide ranging from 0 to 168 M induced considerable apoptosis in both types of cells after 24 h (Figs. 5 and 6 , panels A). p53 and POX, as well as another known p53 gene target (p21 waf1/cip1 ), were induced in response to etoposide treatments (Figs. 5 and 6, panels B and C). The increases in expression of p53 and POX induced by etoposide were associated with increases in the activity of NFAT (Figs. 5 and 6 , panels D). NFAT activity in etoposide-treated cells was inhibited by the VIVIT inhibitor of NFAT, the POX antisense vector (Figs. 5 and 6 , panels D, POX-AS), and the calcineurin inhibitor FK-506 (Figs. 5 and 6, panels D, FK506) . Moreover, inclusion of FK-506 to etoposide-treated cells reduced apoptosis in TOV-21G and DLD1 cells to approximately half that of etoposidetreated cells incubated in the absence of FK-506 (Fig. 7) . DISCUSSION ROS are now appreciated as intracellular second messengers in signaling cascades and induce gene expression by stimulating signal transduction components such as Ca 2ϩ signaling and protein phosphorylation (22) . An extensive number of studies have implicated or shown a direct role for ROS in p53-dependent apoptosis (10, 13, 49 -51) . The big picture that appears to be developing is that p53 plays a role in the transactivation or transrepression of genes involved in the production and control of reactive oxygen intermediates. It is not clear which of the PIGs with activities related to the redox state of the cells is the main source of ROS, but it is likely that a number of the PIGs (including PIG6 or POX) contribute to free radical production and control. P53 can control the production of ROS to initiate apoptosis, but its activity, in turn, is controlled by changes in the cellular redox status. The p53 protein, being in the center of a network of complex redox interactions, may be a mechanism whereby p53 can act as a "detector" of different varieties of stress.
The control of p53 over ROS production mediated through POX may indirectly allow the protein to influence calciumsignaling pathways involved in apoptosis. The induction of POX by p53 increases production of ROS (13) (14) (15) , and ROS can lead to Ca 2ϩ influx into the cytoplasm from the extracellular environment and from intracellular stores (22) . Ca 2ϩ mobilization activates calmodulin/calcineurin, which plays important roles as a multifunctional regulator of apoptosis. We propose that ROS generated by p53-induced POX are signaling molecules that activate the Ca 2ϩ /calcineurin pathway and, in turn, activate NFAT as downstream events in p53-mediated apoptosis. The data presented in this manuscript, where we show that both p53 and POX activate NFAT through processes that are sensitive to calcium and ROS modifiers, support this hypothesis. Moreover, a POX antisense vector blocked p53-in- duced expression of POX and activation of NFAT, implicating POX as a direct downstream mediator of p53-induced activation of calcineurin. In further support of our hypothesis, NFAT is activated by oxidative stress, and this activation is sensitive to ROS scavengers and calcium channel blockers (52) .
Etoposide is a topoisomerase type II inhibitor that induces double-stranded breaks in DNA. Inhibitors of topoisomerase II stabilize DNA-topoisomerase II complexes by blocking DNA replication and thereby cause direct DNA damage (53) . Etoposide up-regulates p53 and activates its DNA binding activity (54, 55) . We observed induction of both p53 and POX, along with the activation of calcineurin, in etoposide-treated ovarian and colon carcinoma cell lines undergoing apoptosis. A POX antisense vector and the calcineurin inhibitor, FK-506, inhibited the etoposide-mediated activation of calcineurin. Blocking calcineurin in the etoposide-treated cells reduced the incidence of apoptosis. Based on these data we conclude that the p53-dependent DNA damage response involves in part the induction of POX, which then generates ROS and stimulates release of Ca 2ϩ from intracellular stores, leading to activation of cal- cineurin. Calcineurin can induce apoptosis by dephosphorylating and thus modulating the activity of different phosphoproteins that are involved in the apoptotic process such as Bcl-2 (56, 57) and Bad (58) . Moreover, factors that modulate calcineurin activity can effect the expression of genes involved in apoptosis. For instance, Bcl-2 can mediate drug resistance and block apoptosis by binding and sequestering calcineurin, preventing the dephosphorylation of NFAT and preventing it from translocating to the nucleus (59). Without NFAT nuclear translocation, the FasL gene is not transcribed.
As shown in this study, Calcineurin is activated by POX and is capable of inducing cytochrome c release from the mitochondria into the cytoplasm. Perhaps this is the reason why the cytochrome c release stimulated by p53 in renal and lung carcinoma cells was suppressed by the expression of a POX antisense vector (14) . Recently, superoxide dismutases, which are important antioxidant enzymes, were shown to inhibit POX-induced apoptosis and release of mitochondrial cytochrome c to the cytosol (15), further implicating the generation of superoxide radicals as playing a crucial role in POX-induced apoptosis. The proline oxidation pathway may be an alternative mechanism to the Bax/Bcl-2 pathway in mediating cytochrome c release by p53 in some cell types such as renal cells and in response to particular conditions of stress. Finally, it is of interest that the DNA binding of p53 to the human immunodeficiency virus type 1 long terminal repeats can be modulated by activated calcineurin (60) . Perhaps POX activates calcineurin, which then further activates p53 and/or alters the DNA binding specificity of p53 for gene targets.
Calcium can activate and inhibit gene transcription through members of the Ca 2ϩ -binding EF-hand superfamily. Calmodulin and calcineurin are representative members of the EF-hand superfamily and can indirectly regulate transcription by influencing the phosphorylation state of transcription factors in response to increases in intracellular Ca 2ϩ (61) . Based on the known effects of ROS on calcium levels in the cell and on the data we present in this manuscript, we propose that POX can mediate changes in gene expression via ROS-induced mobilization of Ca 2ϩ , which then activate calmodulin/calcineurin, leading to changes in the phosphorylation state and activities of transcription factors. The changes in transcription factor activity then lead to changes in gene expression that mediate, in part, p53-dependent apoptosis.
POX expression varies from tissue to tissue. POX activity is high in the liver and kidney of adult rats with moderate expression in the brain and heart and no detectable activity in the lung, skeletal muscle, spleen, or small intestine (62) . The activity of POX also changes as a function of development, undergoing increases in liver and kidney as rats mature from term fetal to adult life (63) . Expression of p53 also is most pronounced during differentiation of the liver and kidney (64) , and up-regulation of p53 occurs in those tissues after ischemiainduced apoptosis in vivo (65) . POX may mediate specific processes of ROS generation that are required during p53-induced apoptosis of certain tissues such as the kidney or contribute other functions required for p53-mediated differentiation of specific tissues.
POX stimulates calcium release into the cytosol from intracellular stores, as evidenced by POX-induced activation of calcineurin and the sensitivity of this activation to Ca 2ϩ modifiers. Ca 2ϩ is a universal signaling molecule that can have effects on many biological and biochemical processes including cell motility, mitochondrial metabolism, secretion, contraction/relaxation, modification and folding of proteins, cell cycle progression, gene expression, and apoptosis (66) . We have found that 8 of 14 primary renal carcinomas either lack or express reduced levels of POX (14) , leading us to speculate that selection against POX expression may promote tumor development and/or progression through dysregulation of one or more of the many cellular processes influenced by Ca 2ϩ .
